BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

721 related articles for article (PubMed ID: 31963461)

  • 1. The Role of CYP450 Drug Metabolism in Precision Cardio-Oncology.
    Fatunde OA; Brown SA
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions between cardiology and oncology drugs in precision cardio-oncology.
    Kamaraju S; Mohan M; Zaharova S; Wallace B; McGraw J; Lokken J; Tierney J; Weil E; Fatunde O; Brown SA
    Clin Sci (Lond); 2021 Jun; 135(11):1333-1351. PubMed ID: 34076246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenomics meets precision cardio-oncology: is there synergistic potential?
    Hockings JK; Castrillon JA; Cheng F
    Hum Mol Genet; 2020 Oct; 29(R2):R177-R185. PubMed ID: 32601683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From cardio-oncology to cardio-onco-pharmacology: Towards a multidisciplinary approach in the understanding and management of cardiotoxicity.
    Ederhy S; Devos P; Cohen A; Pinna B; Bretagne M; Nguyen LS; Salem JE
    Therapie; 2022; 77(2):197-206. PubMed ID: 34895759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenomics for immunotherapy and immune-related cardiotoxicity.
    Castrillon JA; Eng C; Cheng F
    Hum Mol Genet; 2020 Oct; 29(R2):R186-R196. PubMed ID: 32620943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling Precision Cardio-Oncology: Using Human-Induced Pluripotent Stem Cells for Risk Stratification and Prevention.
    Perry TR; Roberts ML; Sunkara B; Maddula R; McLeish T; Gomez J; Lucas J; Rayan D; Patel S; Liang M; Bosnjak ZJ; Brown SA
    Curr Oncol Rep; 2021 May; 23(7):77. PubMed ID: 33937943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Precision Cardio-oncology: Update on Omics-Based Diagnostic Methods.
    Kuang Z; Kong M; Yan N; Ma X; Wu M; Li J
    Curr Treat Options Oncol; 2024 May; 25(5):679-701. PubMed ID: 38676836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiorenal Impact of Anti-Cancer Agents: The Intersection of Onco-Nephrology and Cardio-Oncology.
    Attieh RM; Nunez B; Copeland-Halperin RS; Jhaveri KD
    Cardiorenal Med; 2024; 14(1):281-293. PubMed ID: 38684145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-coding RNAs, cancer treatment and cardiotoxicity: A triad of new hope.
    Mittal R; Krishnan M P S; Saxena R; Sampath A; Goyal B
    Cancer Treat Res Commun; 2023; 36():100750. PubMed ID: 37531735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardio-oncology: Shared Genetic, Metabolic, and Pharmacologic Mechanism.
    Zhao Y; Jia H; Hua X; An T; Song J
    Curr Cardiol Rep; 2023 Aug; 25(8):863-878. PubMed ID: 37493874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mathematical modeling of cardio-oncology: Modeling the systemic effects of cancer therapeutics on the cardiovascular system.
    Casson CL; John SA; Ferrall-Fairbanks MC
    Semin Cancer Biol; 2023 Dec; 97():30-41. PubMed ID: 37979714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Personalized medicine in cardio-oncology: the role of induced pluripotent stem cell.
    Sayed N; Ameen M; Wu JC
    Cardiovasc Res; 2019 Apr; 115(5):949-959. PubMed ID: 30768178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Precision Medicine in Oncology Pharmacy Practice.
    Saadeh C; Bright D; Rustem D
    Acta Med Acad; 2019 Apr; 48(1):90-104. PubMed ID: 31264437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Precision Cardio-Oncology.
    Dreyfuss AD; Bravo PE; Koumenis C; Ky B
    J Nucl Med; 2019 Apr; 60(4):443-450. PubMed ID: 30655328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [2022 ESC guidelines on cardio-oncology : Understanding and treating cardiovascular side effects from cancer therapy].
    Michel L; Totzeck M; Rassaf T
    Herz; 2023 Feb; 48(1):15-22. PubMed ID: 36441175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardio-Oncology: Mechanisms, Drug Combinations, and Reverse Cardio-Oncology.
    Liang Z; He Y; Hu X
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Updates on cytochrome P450-mediated cardiovascular drug interactions.
    Cheng JW; Frishman WH; Aronow WS
    Am J Ther; 2009; 16(2):155-63. PubMed ID: 19114873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardio-Oncology: How New Targeted Cancer Therapies and Precision Medicine Can Inform Cardiovascular Discovery.
    Bellinger AM; Arteaga CL; Force T; Humphreys BD; Demetri GD; Druker BJ; Moslehi JJ
    Circulation; 2015 Dec; 132(23):2248-58. PubMed ID: 26644247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardio-Oncology-Beyond Anthracyclines and Ejection Fraction.
    Geenty PD; Gregory AT; Nolan M; Denniss AR; Pepe S; Sverdlov AL; Thomas L
    Heart Lung Circ; 2024 May; 33(5):547-552. PubMed ID: 38823894
    [No Abstract]   [Full Text] [Related]  

  • 20. Cardiovascular Imaging in Cardio-Oncology: The Role of Echocardiography and Cardiac MRI in Modern Cardio-Oncology.
    Gambril JA; Chum A; Goyal A; Ruz P; Mikrut K; Simonetti O; Dholiya H; Patel B; Addison D
    Heart Fail Clin; 2022 Jul; 18(3):455-478. PubMed ID: 35718419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.